Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01 to 1.49) compared with serum 25(OH)D sufficiency.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Participants were classified as active (engaging in vigorous or moderate physical activity more than once per week) or sedentary (engaging in vigorous or moderate physical activity once a week, one to three times per month, hardly ever or never, and any light physical activity).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Is serum 25‐hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing
Study design awaiting verification · Diabetes, Obesity & Metabolism · 2025
Original publication title
Is serum 25‐hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing
© 2025 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Cross‐sectional studies demonstrate an association between low serum levels of vitamin D and slower gait speed in older individuals. However, longitudinal studies remain inconclusive. This study investigates whether vitamin D deficiency and insufficiency are risk factors for the incidence of slowness.
Source: AimsAbstract: What methods does the paper describe?
A total of 2815 participants from the English Longitudinal Study of Ageing (ELSA), aged ≥60 years and with a baseline gait speed >0.8 m/s, were followed for six years. Baseline serum levels of vitamin D [25(OH)D] were categorized as “sufficiency” (>50 nmol/L), “insufficiency” (>30 and ≤50 nmol/L) or “deficiency” (≤30 nmol/L). Gait speed was reassessed at four and six years of follow‐up to identify incident cases of slowness (walking speed ≤0.8 m/s). A Poisson regression model, adjusted for sociodemographic, behavioural and clinical characteristics at baseline, was conducted to determine the association between serum 25(OH)D levels and the risk of slowness.
Source: Materials and MethodsAbstract: Results
The incidence densities of slowness per 1000 person‐years were 67.4 (95% CI: 60.93 to 74.64) for sufficiency, 76.7 (95% CI: 68.30 to 86.22) for insufficiency and 90.7 (95% CI: 78.46 to 104.92) for deficiency. Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01 to 1.49) compared with serum 25(OH)D sufficiency. No significant association was observed for serum 25(OH)D insufficiency.
Source: ResultsAbstract: Conclusions
Serum 25(OH)D deficiency is a risk factor for the incidence of slowness in older individuals, suggesting that maintaining sufficient 25(OH)D levels could be a strategic approach to minimise long‐term mobility impairment.
Source: ConclusionsAuthors’ abstract
Abstract
Aims
Cross‐sectional studies demonstrate an association between low serum levels of vitamin D and slower gait speed in older individuals. However, longitudinal studies remain inconclusive. This study investigates whether vitamin D deficiency and insufficiency are risk factors for the incidence of slowness.
Materials and Methods
A total of 2815 participants from the English Longitudinal Study of Ageing (ELSA), aged ≥60 years and with a baseline gait speed >0.8 m/s, were followed for six years. Baseline serum levels of vitamin D [25(OH)D] were categorized as “sufficiency” (>50 nmol/L), “insufficiency” (>30 and ≤50 nmol/L) or “deficiency” (≤30 nmol/L). Gait speed was reassessed at four and six years of follow‐up to identify incident cases of slowness (walking speed ≤0.8 m/s). A Poisson regression model, adjusted for sociodemographic, behavioural and clinical characteristics at baseline, was conducted to determine the association between serum 25(OH)D levels and the risk of slowness.
Results
The incidence densities of slowness per 1000 person‐years were 67.4 (95% CI: 60.93 to 74.64) for sufficiency, 76.7 (95% CI: 68.30 to 86.22) for insufficiency and 90.7 (95% CI: 78.46 to 104.92) for deficiency. Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01 to 1.49) compared with serum 25(OH)D sufficiency. No significant association was observed for serum 25(OH)D insufficiency.
Conclusions
Serum 25(OH)D deficiency is a risk factor for the incidence of slowness in older individuals, suggesting that maintaining sufficient 25(OH)D levels could be a strategic approach to minimise long‐term mobility impairment.
Publication and source details
Original title: Is serum 25‐hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing
Mariane Marques Luiz; Roberta de Oliveira Máximo; Aline Fernanda de Souza; Thales Batista de Souza; Sara Souza Lima; Leticia Coelho Silveira; Thaís Barros Pereira da Silva; Andrew Steptoe; Cesar de Oliveira; Tiago da Silva Alexandre
Diabetes, Obesity & Metabolism · 2025
* CorrespondenceTiago da Silva Alexandre, Gerontology Department, Rodovia Washington Luís, km 235, SP‐310, Sao Carlos, Sao Paulo, Brazil.
Email: tiagoalexandre@ufscar.br
© 2025 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Fundação de Amparo à Pesquisa do Estado de São Paulo 10.13039/50110000180718/13917‐3Economic and Social Research Council 10.13039/501100000269ES/T008822/11Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 10.13039/50110000232200188887.717097/2022‐00Conselho Nacional de Desenvolvimento Científico e Tecnológico 10.13039/501100003593303577/2020‐7305338/2023‐4National Institute on Aging 10.13039/100000049R01AG017644
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:52:29.901028+00:00
DOI: 10.1111/dom.16317 · PMC12046445